Cure51 raises a €15 million seed round to harness the natural power of cancer survivors and contribute to cure this life threatening disease

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

Cure51-Seed-Round

More Like This

How Cutting-Edge Immunotherapies Are Redefining Cancer Treatment Options

Sofinnova Partners and Gustave Roussy forge strategic alliance to boost oncology startup acceleration in France

Brenus Pharma, Winner of the Call for Proposals "Innovations in Biotherapies and Bioproduction for France 2030", Receives €5 Million for Its Anticancer Vaccine Immunotherapy

Surge announces closing of a €7.5 million fundraising round to decrypt the immune system and transform precision medicine

Edward Kliphuis, Partner, Sofinnova Digital Medicine Strategy and Simon Turner, Partner, Sofinnova Digital Medicine Strategy (Photo: Sofinnova Partners)

Sofinnova Partners Raises $200M Digital Medicine Fund

Brenus Pharma Joins the Paris Saclay Cancer Cluster (PSCC) to Collaborate at the Heart of Innovation in Oncology

UK-backed AI companies to transform British cancer care and spark new drug breakthroughs

PR Newswire associated0

MGI: Closing the Cancer Care Gap with the Power of Precision Oncology